Last reviewed · How we verify

High dose vitamin C — Competitive Intelligence Brief

High dose vitamin C (High dose vitamin C) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin/Antioxidant. Area: Oncology.

marketed Vitamin/Antioxidant Oncology Small molecule Live · refreshed every 30 min

Target snapshot

High dose vitamin C (High dose vitamin C) — Seoul National University Hospital. High-dose intravenous vitamin C acts as a pro-oxidant to generate reactive oxygen species that selectively damage cancer cells while supporting immune function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
High dose vitamin C TARGET High dose vitamin C Seoul National University Hospital marketed Vitamin/Antioxidant
Vitamin E 400 UNT Vitamin E 400 UNT American British Cowdray Medical Center marketed Vitamin/Antioxidant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin/Antioxidant class)

  1. American British Cowdray Medical Center · 1 drug in this class
  2. Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). High dose vitamin C — Competitive Intelligence Brief. https://druglandscape.com/ci/high-dose-vitamin-c. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: